Investigation of The Factors of The 5-year Prognosis and Medical Resource Consumption for Cervical Cancer Patients

• Main Authors: Kuo-Feng Weng, 翁國峰
• Other Authors: Che-Ming Yang
• Format: Others
• Language: zh-TW
• Published: 2016
• Online Access: http://ndltd.ncl.edu.tw/handle/hes8y8

碩士 === 臺北醫學大學 === 醫務管理學研究所 === 104 === Background: According to the report of World Health Organization (WHO), cervical cancer is the second leading type of cancers for women. Taiwan NHI provides the free Pap smear screening for over 30-years old women once yearly in order to early treatment. As a result, the amount of cervical cancer patients decreases from 2,942 (1996) to 1,673 (2001) in Taiwan. The cervical mortality rates decrease from 10.5 per hundred thousand females (1996) to 4 per hundred thousand females (2003). However, the HPA annual Report of cancer registration in 2002 has reported cervical cancer is the seventh of the death factors for women. Therefore, the patients with regular Pap tests and symptoms at diagnosis of the severity are related. Purpose: Based on NHI database, studying the duration of cancer recurrence, hospital mortality and medical resource consumption of cervical cancer patients. Method: This study used NHI database 2010 version which select cervical cancer patient from 2004 to 2008. Every entry was followed up for 5 years. SAS 9.4 were used for analysis. Conlusion: This study demonstrated that the patients who accepted the surgery treatment (n=108) were still alive within five year tracking records.. The annual average number of maternity clinics before diagnosis was 4.41 ± 4.38. The annual average number of pap smear test was 1.58 ± 1.23. The severity of illness was 1.87 ± 1.03. The total cost of hospitalization was NTD490,432.50 ± 435,811.93. On the other hand, the patients who dead within five year tracking record, are accepted the radiation treatment (n=8). The annual average number of maternity clinics before diagnosis was 2.89 ± 1.45. The annual average number of pap smear test was 1.89 ± 1.17. The severity of illness was 2.67 ± 1.66. The total cost of hospitalization was NTD490,432.50 ± 435,811.93 and had dramatically divergences (P<0.0001). The total cost of hospitalization for cancer recurrence was also dramatically divergences (P=0.0426). In this study, we conjectured taking pap smear test regularly benefits the survival rate of cervical cancer patients with five year tracking duration. So that they can get treatment immediately, and the treatment outcome will be better when suffering cervical cancer in the early stage. About the patients who dead with first five years, it will be more difficult to treat and cost more due to the late stage of cervical cancer.